Minireviews
Copyright ©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Exp Med. Nov 30, 2018; 8(3): 18-23
Published online Nov 30, 2018. doi: 10.5493/wjem.v8.i3.18
Circulating microRNAs as biomarkers for diabetic neuropathy: A novel approach
Eleni Xourgia, Athanasia Papazafiropoulou, Andreas Melidonis
Eleni Xourgia, Athanasia Papazafiropoulou, Andreas Melidonis, 1st Department of Internal Medicine and Diabetes Center, Tzaneio General Hospital of Piraeus, Athens 18536, Greece
Author contributions: All authors equally contributed to this paper with conception and design of the study, literature review and analysis, drafting and critical revision and editing, and final approval of the final version.
Conflict-of-interest statement: No potential conflicts of interest. No financial support.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author to: Athanasia Papazafiropoulou, MD, MSc, PhD, Attending Doctor, 1st Department of Internal Medicine and Diabetes Center, Tzaneio General Hospital of Piraeus, 1 Zanni and Afentouli Street, Athens 18536, Greece. pathan@ath.forthnet.gr
Telephone: +30-697-996483
Received: October 13, 2018
Peer-review started: October 15, 2018
First decision: November 1, 2018
Revised: November 5, 2018
Accepted: November 15, 2018
Article in press: November 15, 2018
Published online: November 30, 2018
Processing time: 61 Days and 17.6 Hours
Core Tip

Core tip: In this review, we aim to create a concise overview of the epigenetics underlining the pathogenesis of diabetic neuropathy with emphasis on the altered microRNA expression patterns identified on both animal and human subjects, while, exploring the manner by which they could be manipulated and utilized as novel therapeutic targets.